Marie Törngren
VP Non-clincal R&D at Active Biotech AB- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Active Biotech AB
-
Biotechnology
-
1 - 100 Employee
-
VP Non-clincal R&D
-
Jan 2022 - Present
-
-
-
-
Director Preclinical Development
-
Sep 2018 - Sep 2018
-
-
Director of Preclinical Development
-
Sep 2018 - Sep 2018
-
-
Head of Pharmacology
-
Sep 2008 - Sep 2018
Manages a team of scientists and technicians performing in vivo studies for PK evaluation, PK/PD models, disease models for cancer and autoimmunity, as well as dose finding studies before pivotal toxicology studies. Histological and immunohistochemical lead. Representing ActiveBiotech AB and six other companies that rent lab space at AB, towards Swedish Agricultural Board.Provides pharmacological, tox/safety and histological expertize to several projects.
-
-
Scientist
-
Sep 2002 - Sep 2008
Histological and immunohistochemical lead.Planned and led in vivo studies in PK/PD and disease models for cancer and autoimmunity as well as dose finding studies before pivotal tox and safety studies.
-
-
-
-
Scientist, Group Leader
-
Jun 2001 - Jan 2002
Managed a team of scientists and technicians providing in vivo and in vivo/ex vivo studies supporting several projects. Planned and led in vivo studies in PK/PD and disease models for cancer and autoimmunity as well as dose finding studies before pivotal tox and safety studies Managed a team of scientists and technicians providing in vivo and in vivo/ex vivo studies supporting several projects. Planned and led in vivo studies in PK/PD and disease models for cancer and autoimmunity as well as dose finding studies before pivotal tox and safety studies
-
-
-
Lund Universty
-
Sweden
-
Higher Education
-
300 - 400 Employee
-
Wallenberg Retina Center
-
Feb 2000 - Jun 2001
Characterization of retinal development in culture, using PCR and immunohistochemistry on retinal explants from rats. The studies on explanted retinas were concentrated on developmental and differentiation events of different cell subtypes Published three papers and presented three posters Characterization of retinal development in culture, using PCR and immunohistochemistry on retinal explants from rats. The studies on explanted retinas were concentrated on developmental and differentiation events of different cell subtypes Published three papers and presented three posters
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Research Scientist
-
Dec 1998 - Jan 2000
Histological and immunohistochemical lead on an inflammation pharmacology team. Planned and led in vivo studies in inflammation models supporting several projects. Histological and immunohistochemical lead on an inflammation pharmacology team. Planned and led in vivo studies in inflammation models supporting several projects.
-
-
Education
-
Lund University
PhD, Zoology, functional morphology -
Lund University
Bachelor of Science, Biology, Chemistry -
Tekniska skolan, Hässleholm
Science program (3 years)